Exploring Genetic Clues in Kikuchi-Fujimoto Disease: A Three-Generation Study.

IF 2.4 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Pharmacogenomics & Personalized Medicine Pub Date : 2026-09-06 eCollection Date: 2026-01-01 DOI:10.2147/PGPM.S602876
Cheryl Weiqi Tan, Gayatiri Raveentheran, Khadijah Rafi'ee, Lena Das, Mark Jean-Aan Koh, Ene-Choo Tan
{"title":"Exploring Genetic Clues in Kikuchi-Fujimoto Disease: A Three-Generation Study.","authors":"Cheryl Weiqi Tan, Gayatiri Raveentheran, Khadijah Rafi'ee, Lena Das, Mark Jean-Aan Koh, Ene-Choo Tan","doi":"10.2147/PGPM.S602876","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Kikuchi-Fujimoto disease (KFD) is a rare disorder involving necrotizing lymphadenitis which was first described in Japan. The presentations include lymphadenopathy, fever, and leukopenia of unknown cause.</p><p><strong>Patient: </strong>A 2-year-old Malay girl was evaluated and diagnosed with KFD after presenting with prolonged fever and rash. Her parents are not biologically related, but there is a strong family history of KFD on the maternal side of the family. We investigated the genetic profiles of the patient, her mother and grandmother, who also had a history of similar presentations.</p><p><strong>Methods: </strong>High-resolution HLA typing was performed on the family to examine the potential associations with HLA genotypes. Next-generation sequencing using a Mendelian gene panel was performed on the child's sample, followed by targeted Sanger sequencing of shortlisted variants for the family members.</p><p><strong>Results: </strong>The three affected family members share 14 HLA alleles that are not present in the healthy father, among which five have reported associations with autoimmune inflammatory disorders. Two of them (DQA1*02:01 and DRB1*07:01) were also reported in a pair of affected twins from Australia. In addition to HLA, three rare missense variants in immune-related genes (<i>FGFR3, NRP2</i> and <i>PCM1</i>) were found to correlate with the presence of symptoms within the family. The three affected members also had at least one of the variants in the <i>C1QC</i> gene (a missense and a 17-nucleotide deletion), which is part of the complement pathway that might be related to KFD.</p><p><strong>Conclusion: </strong>Our study uncovers some HLA alleles and immune gene variants that might be important in the development of KFD. Large-scale sequencing of immune genes may be as important as high-resolution HLA typing in identifying genetic factors contributing to KFD pathogenesis. HLA studies provide risk associations to KFD, while association with variants in immune genes may reveal pathways in the development of KFD.</p>","PeriodicalId":56015,"journal":{"name":"Pharmacogenomics & Personalized Medicine","volume":"19 ","pages":"602876"},"PeriodicalIF":2.4000,"publicationDate":"2026-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13560947/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics & Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PGPM.S602876","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Kikuchi-Fujimoto disease (KFD) is a rare disorder involving necrotizing lymphadenitis which was first described in Japan. The presentations include lymphadenopathy, fever, and leukopenia of unknown cause.

Patient: A 2-year-old Malay girl was evaluated and diagnosed with KFD after presenting with prolonged fever and rash. Her parents are not biologically related, but there is a strong family history of KFD on the maternal side of the family. We investigated the genetic profiles of the patient, her mother and grandmother, who also had a history of similar presentations.

Methods: High-resolution HLA typing was performed on the family to examine the potential associations with HLA genotypes. Next-generation sequencing using a Mendelian gene panel was performed on the child's sample, followed by targeted Sanger sequencing of shortlisted variants for the family members.

Results: The three affected family members share 14 HLA alleles that are not present in the healthy father, among which five have reported associations with autoimmune inflammatory disorders. Two of them (DQA1*02:01 and DRB1*07:01) were also reported in a pair of affected twins from Australia. In addition to HLA, three rare missense variants in immune-related genes (FGFR3, NRP2 and PCM1) were found to correlate with the presence of symptoms within the family. The three affected members also had at least one of the variants in the C1QC gene (a missense and a 17-nucleotide deletion), which is part of the complement pathway that might be related to KFD.

Conclusion: Our study uncovers some HLA alleles and immune gene variants that might be important in the development of KFD. Large-scale sequencing of immune genes may be as important as high-resolution HLA typing in identifying genetic factors contributing to KFD pathogenesis. HLA studies provide risk associations to KFD, while association with variants in immune genes may reveal pathways in the development of KFD.

探索菊池-藤本病的遗传线索:三代研究。
背景:菊池-藤本病(KFD)是一种罕见的疾病,涉及坏死性淋巴结炎,首次在日本发现。表现包括淋巴结病、发热和不明原因的白细胞减少。患者:一名2岁的马来女孩在出现持续发烧和皮疹后被评估并诊断为KFD。她的父母没有血缘关系,但母亲有强烈的KFD家族史。我们调查了患者、她的母亲和祖母的基因图谱,他们也有类似的病史。方法:对该家族进行高分辨率HLA分型,以检验其与HLA基因型的潜在关联。使用孟德尔基因面板对儿童样本进行下一代测序,然后对家庭成员的候选变体进行针对性的桑格测序。结果:三名受影响的家庭成员共有14个HLA等位基因,这些等位基因在健康父亲中不存在,其中有5个被报道与自身免疫性炎症疾病有关。其中2例(DQA1*02:01和DRB1*07:01)也在澳大利亚的一对患病双胞胎中报告。除HLA外,还发现免疫相关基因中的三种罕见错义变异(FGFR3、NRP2和PCM1)与家族中症状的存在相关。三名受影响的成员也至少有一种C1QC基因变异(错义和17个核苷酸缺失),这是补体途径的一部分,可能与KFD有关。结论:我们的研究揭示了一些HLA等位基因和免疫基因变异可能在KFD的发展中起重要作用。在确定KFD发病机制的遗传因素方面,免疫基因的大规模测序可能与高分辨率HLA分型一样重要。HLA研究提供了与KFD的风险关联,而与免疫基因变异的关联可能揭示了KFD发展的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacogenomics & Personalized Medicine
Pharmacogenomics & Personalized Medicine Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
3.30
自引率
5.30%
发文量
110
审稿时长
16 weeks
期刊介绍: Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. In particular, emphasis will be given to: Genomic and proteomic profiling Genetics and drug metabolism Targeted drug identification and discovery Optimizing drug selection & dosage based on patient''s genetic profile Drug related morbidity & mortality intervention Advanced disease screening and targeted therapeutic intervention Genetic based vaccine development Patient satisfaction and preference Health economic evaluations Practical and organizational issues in the development and implementation of personalized medicine programs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书